Related Experiment Video
Updated: Jul 10, 2026
06:57
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Amebic colitis: new insights into pathogenesis and treatment
Tracy E Bercu1, William A Petri, Jr W Behm
1Division of Infectious Diseases and International Health, University of Virginia Health System, P.O. Box 801340, Charlottesville, VA 22908, USA. Wap3g@virginia.edu
Current Gastroenterology Reports
|November 10, 2007
Summary
Amebiasis, a parasitic infection affecting millions globally, causes significant deaths. Understanding Entamoeba histolytica infection mechanisms and host factors may lead to new detection and treatment strategies.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Immunology
Background:
- Amebiasis, caused by Entamoeba histolytica, is a major global health concern, impacting over 50 million people and causing over 100,000 deaths annually.
- While many infections are asymptomatic, a significant portion (10%) leads to severe morbidity and mortality.
- Recent scientific progress offers new avenues for combating this disease.
Purpose of the Study:
- To review the current understanding of Entamoeba histolytica infection mechanisms.
- To explore the role of the innate immune system and genetic predisposition in amebiasis.
- To discuss advancements in detection, treatment, and overall management of amebiasis.
Main Methods:
- Literature review of recent advances in amebiasis research.
- Analysis of studies on Entamoeba histolytica pathogenesis.
- Synthesis of information on clinical manifestations and therapeutic strategies.
Main Results:
- Understanding of E. histolytica infection mechanisms has advanced.
- The interplay between the parasite, innate immunity, and host genetics is becoming clearer.
- Novel detection and treatment methods are being developed.
Conclusions:
- Continued research into Entamoeba histolytica is crucial for developing effective interventions.
- Targeting host-parasite interactions and genetic factors may yield breakthrough treatments.
- Improved diagnostics and therapies are anticipated based on recent scientific discoveries.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...